Delivery Order SPE2DB20D3101-SPE2DB25FQTQ6
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.07 firm fixed-price delivery order is for KETOROLAC 30 MG/ML VIALML, a generic pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.84 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a pain medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,172.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Ketorolac 60 mg/2 ml vials, a pharmaceutical product, with a performance period extending to March 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $4,911.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 0.5% Ophthalmic Solution, a medication used to treat eye pain and inflammation. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vials. The contract, valued at $1,318.38, is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a value of $1,819.97 and is a Delivery Order type with a Firm Fixed Price pricing structure. It covers the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, with a period of performance through March 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,241.55 firm-fixed-price delivery order is for the supply of 4567454071 KETOROLAC 60 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a March 5, 2025 completion date and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ketorolac 30mg/ml 25s, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,029.16, is a firm fixed-price delivery order contract with a completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. The $1,560.38 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL pharmaceutical vials. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as...